En Europa, Eisai realiza ventas y operaciones de comercialización en más de 20 mercados, como el Reino Unido, Francia, Alemania, Italia, España, Suiza, Suecia, Irlanda, Austria, Dinamarca, Finlandia, Noruega, Portugal, Islandia, República Checa, Hungría y Eslovaquia.
Para más información, visite nuestra página web http://www.eisai.com
Bibliografía
1. EISAI (JP4523.TK)Ltd. (2005). Zonegran Summary of Product Characteristics [http://www.medicines.org.uk/emc/ [http://www.medicines.org.uk/emc ] ]
2. Pugliatti M et al. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia 2007: 48(12) 2224 - 2233
3. ILAE/IBE/WHO, Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. Available from; http://www.ilae-epilepsy.org/visitors/documents/euroreport160510.pdf (Accessed June 2011)
4. Epilepsy Society UK: http://www.epilepsysociety.org.uk/aboutepilepsy/whatisepilepsy/epilepsy-didyouknow (Accessed June 2011)
5. Eisai. Data on file
6. Epilepsy Research UK. What is Epilepsy? Fact sheet. Available from URL: http://www.epilepsyresearch.org.uk/about_us/leaflets/lflt1.htm (Accessed June 2011)
CONTACTO: Media Enquiries, Eisai Europe Ltd, Cressida Robson,+44-7908-314-155, Cressida_Robson@eisai.net; Tonic Life Communications,Benjamyn Tan / Helen Swift, +44(0)7747111217 / +44(0)207-798-9900,benjamyn.tan@toniclc.com, helen.swift@toniclc.com
